Fig. S2 from The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing NOTCH1 Expression and Targeting Tumor-Initiating Cells
Year: 2023
Type: other
Abstract: Supplementary Fig S2. SCLC TICs are enriched for stem cell markers. A, B, C, Expression levels of SOX2, NANOG and OCT4 mRNAs in CD133high and CD133low H82 (A) and H526 (B) cells or CD44high and CD44low H446 (C) cells. D, Levels of SOX2 and OCT4, determined by Western analysis in CD133high and CD133low H82 and H526 cells or CD44high and CD44low H446 cells.
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361256965